Your browser doesn't support javascript.
loading
What's new in WHO fifth edition - urinary tract.
Compérat, Eva; Amin, Mahul B; Berney, Dan M; Cree, Ian; Menon, Santosh; Moch, Holger; Netto, George J; Rao, Vishal; Raspollini, Maria Rosaria; Rubin, Mark A; Srigley, John R; Tan, Puay Hoon; Tickoo, Satish Kumar; Turajlic, Samra; Tsuzuki, Toyonori.
Affiliation
  • Compérat E; Department of Pathology, General Hospital, Medical University Vienna, Vienna, Austria.
  • Amin MB; Department of Pathology, Hôpital Tenon, Sorbonne University, Paris, France.
  • Berney DM; Department of Pathology and Laboratory Medicine, University of Tennessee Health Sciences Center, Knoxville, TN, USA.
  • Cree I; Department of Urology, University of Southern California, Keck School of Medicine, Los Angeles, CA, USA.
  • Menon S; Department of Cellular Pathology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Moch H; Barts Health NHS Trust, London, UK.
  • Netto GJ; International Agency for Research on Cancer (IARC), World Health Organisation, Lyon, France.
  • Rao V; Department of Pathology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Raspollini MR; Department of Pathology and Molecular Pathology, University Hospital Zurich and University Zurich, Zurich, Switzerland.
  • Rubin MA; Department of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.
  • Srigley JR; Department of Pathology and Molecular Pathology, University Hospital Zurich and University Zurich, Zurich, Switzerland.
  • Tan PH; Histopathology and Molecular Diagnostics, Careggi Hospital, University of Florence, Florence, Italy.
  • Tickoo SK; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Turajlic S; Bern Center for Precision Medicine and Department for Biomedical Research, Bern, Switzerland.
  • Tsuzuki T; Trillium Health Partners and University of Toronto, Mississauga, ON, Canada.
Histopathology ; 81(4): 439-446, 2022 Oct.
Article in En | MEDLINE | ID: mdl-35942645
ABSTRACT
The fifth edition of the WHO Blue Book on urological tumours, specifically in the bladder chapter, represents a refinement and update in the classification of bladder tumours building on the aggregate major changes made in previous editions. Progress in the molecular underpinnings of urothelial tumours, particularly with promising stratifiers for more precision-based treatment approaches, have been made. Special attention has been paid to burning questions in bladder pathology, such as grading, heterogeneous lesions, inverted tumours and substaging. The concept of neuroendocrine tumours will be explained precisely.
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Tract / Urinary Bladder Neoplasms / Urologic Neoplasms Limits: Humans Language: En Journal: Histopathology Year: 2022 Document type: Article Affiliation country: Austria
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Tract / Urinary Bladder Neoplasms / Urologic Neoplasms Limits: Humans Language: En Journal: Histopathology Year: 2022 Document type: Article Affiliation country: Austria